AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion
December 06, 2023 at 17:06 PM EST
The deal is AbbVie's latest attempt to expand its drug pipeline as its top-selling treatments, such as Humira, face generic competition.
